Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
AIDS and HIV
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - AIDS and HIV
    TopAbstracts in AIDS and HIV 11/23/2009 - (DGNews)
    TopAbstracts in AIDS and HIV 11/09/2009 - (DGNews)
    Use of Lymphosum Tube to Double-Check Low CD4 Counts Is Unnecessary: Presented at ASCP - (DGDispatch)
    Neurocognitive Issues Plague HIV-Infected Patients Taking Antiretroviral Therapy: Presented at IDSA - (DGDispatch)
    Antiretroviral-Experienced Patients Maintain HIV Suppression Through 144 Weeks: Presented at IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - AIDS and HIV
      Prevention With Positives In HIV Medical Care
      Non-AIDS-Defining Cancers in Patients with HIV Infection
      Management of an HIV-Infected Patient After Initial Antiretroviral Regimen Failure
      The Use of Chemokine Receptor Antagonists in Antiretroviral Treatment Failure
      Issues in the Care of HIV and Hepatitis C Virus-coinfected Patients: Antiretroviral Pharmacokinetics, Drug Interactions, and Liver Transplantation

      Webcasts/CME archive

       Recent cases - AIDS and HIV
        A Patient with Neck Pain and Fever
        Rapid and Persistent Selection of the K103N Mutation as a Majority Quasispecies in a HIV1-Patient Exposed to Efavirenz for Three Weeks: A Case Report and Review of the Literature
        Newly Formed Cystic Lesions for the Development of Pneumomediastinum in Pneumocystis Jirovecii Pneumonia
        Bordetella Bronchiseptica Pneumonia in a Man with Acquired Immunodeficiency Syndrome: A Case Report
        HIV Care for the Primary Care Physician

        Cases archive
          




        my personal edition > aids and hiv > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Antiretroviral Treatment During Pregnancy Effective in Preventing HIV Transmission From Mothers to Newborns: Presented at AIDS 2008

          By Ed Susman

          MEXICO CITY -- August 5, 2008 -- The use of antiretroviral therapy during pregnancy among women infected with human immunodeficiency virus (HIV) reduces the transmission rate to newborns to less than 1%, according to study findings presented here at the 17th International AIDS Conference (AIDS 2008).

          In a prospective treatment review presented here at a poster session on August 4, John C. Forbes, MD, Oak Tree Clinic, University of British Columbia, Vancouver, British Columbia, described outcomes among 1,980 babies delivered by HIV-infected Canadian women since 1990. The mothers of 1,066 of those children were treated with highly active antiretroviral therapy (HAART), and the rate of transmission of HIV was 1.2%. If the women received only some antiretroviral therapy, the transmission rate was 3.4%; if the mothers received no antiretroviral therapy, the transmission rate was 21.4%.

          "The decline in Canada's HIV vertical transmission rate shows the success of Canadian prenatal, perinatal, and postnatal HIV prevention programs," Dr. Forbes said, speaking on behalf of his colleagues in the Canadian Pediatric AIDS Research Group. "A few HIV-infected children are still born in Canada each year. This highlights a need to further optimise our prevention strategies by improving access to women in injecting-drug use, aboriginal, and immigrant populations."

          The success of the HIV prevention program was illustrated by 2007 statistics. A total of 161 babies were born to women who received HAART during pregnancy. None of those babies was HIV infected. An additional 8 children were born to mothers who received some antiretroviral therapy. None of those children was HIV infected. Of the 26 children who were born to mothers who did not receive any prenatal antiretroviral therapy, only 1 child (3.8%) was born HIV infected, Dr. Forbes said.

          "Renewed efforts should be made to avoid 'missed opportunities' of prevention," Dr. Forbes concluded. Among those efforts are included universal implementation of HIV testing in pregnancy; improved access to prenatal care among marginalised groups such as addicted persons; testing partners of patients; and retesting for HIV during the third trimester of pregnancy.


          [Presentation title: Perinatal HIV Transmission and Demographics in Canada: Data From the Canadian Perinatal HIV Surveillance Program (CPHSP) Since 1990. Abstract MOPE0215]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send